Back to search
FDAFDA · Food and drugs·Recall number D-1334-2014

XZONE GOLD, 1 capsule blister 750 mg, Distributed by: XZONE, Orlando, FL.

Published May 28, 2014 · Recall initiated: January 9, 2014

Summary

FDA records drug Class I recall D-1334-2014, published May 28, 2014 and initiated January 9, 2014. Recalling firm: Schindele Enterprises dba Midwest Wholesale; Status: Terminated; Reported quantity: 175 blister packs; Lot: Lot # 130710GL, Exp. 07/31/2018. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, an analogue of sildenafil, and/or tadalafil.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Schindele Enterprises dba Midwest Wholesale
Distributor
Distributed to PA, IL, TX, IA, GA, CT, FL, CA, LA, NY, MD, NV, and WI
Lot
Lot # 130710GL, Exp. 07/31/2018
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was XZONE GOLD, 1 capsule blister 750 mg, Distributed by: XZONE, Orlando, FL. recalled?

Yes. FDA published recall D-1334-2014 on May 28, 2014. Reported hazard: Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, an analogue of sildenafil, and/or tadalafil.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release